PHARMACOSOMES: A POTENTIAL VESICULAR DRUG DELIVERY SYSTEM
Abstract
Lipid based drug delivery systems have been examined in various studies and exhibited their potential in controlled and targeted drug delivery. Pharmacosomes, a novel vesicular drug delivery system, offering a unique advantage over liposomes and niosomes, and serve as potential alternative to these conventional vesicles. They constitute an amphiphilic phospholipid complex with drug bearing an active hydrogen atom covalently that bind to phospholipids. They provide an efficient delivery of drug required at the site of action, which ultimately reduces the drug toxicity with reduced adverse effects and also reduces the cost of therapy by imparting better biopharmaceutical properties to the drug, resulting in increases bioavailability, especially in case of poorly soluble drugs. As the system is formed by binding the drug (pharmakon) to carrier (soma), they are termed as pharmacosomes. Depending upon the chemical structure of the drug lipid complex they may exist as ultrafine vesicular, micellar and hexagonal aggregate. Drug having active hydrogen group such as carboxyl, hydroxyl group can be esterified to lipids, resulting in amphiphilic compound. Pharmacosomes are widely used as carriers for various non-steroidal anti-inflammatory drugs, proteins, cardiovascular and antineoplastic drugs. The release of drug from pharmacosomes is generally governed by the process of enzymatic reaction and acid hydrolysis. Here, in the present review paper we have discussed the potential of pharmacosomes as a controlled and targeted drug delivery system and highlighted the method of preparation and characterization.
Keywords:
Pharmacosomes, amphiphilic, targeted drug delivery system, biosomes, phospholipids, bioavailabilityDOI
https://doi.org/10.25004/IJPSDR.2014.060202References
2. Biju SS, Talegaonkar S, Mishra PR, Khar KR. Vesicular System: An overveiw. Indian J. Pharm Sci, 2009; 71(4): 421-427.
3. Jin Y et al. Self-assembled drug delivery systems- Properties and in vitro-in vivo behavior of acyclovir self-assembled nanoparticles, Int J Pharm, 2006; 309(1–2): 199-207.
4. Doijad Rajendra C, Bhambere Deepak S, Manvi Fakirappa V, Deshmukh Narendra V. Formulation and characterization of vesicular drug delivery system for Anti-HIV drug. Journal of Global Pharma Technology, 2009; 1: 94-100.
5. Prajapati SK, Kumar S, Sahu VK, Prakash G. Proniosomal gel of flurbiprofen: Formulation and evaluation. Journal of Drug Delivery & Therapeutics, 2012; 2:105-114.
6. Gangwar M, Singh R, Goel RK, Nath G. Recent advances in various emerging vesicular systems: An Overview. Asian Pacific Journal of Tropical Biomedicine, 2011; 33: 848.
7. Bangham AD, Standish MM, Watkins JG. The action of steroids and streptolysin S on the permeability of phospholipid structures to cations. J Mol Biol, 1965; 13: 238.
8. Ogihara U, Sasaki T, Toyama H, Odak SM, Nishigori H. Cancer Detect Prev, 1997; 21(6): 490.
9. Kavitha D, Naga Sowjanya J, Shanker P. Pharmacosomes: An emerging vesicular system. International Journal of Pharmaceutical Sciences Review and Research, 2010; 5(3):168-171.
10. Semalty A, Semalty M, Singh D, Rawat MS. Development and characterization of aspirin-phospholipid complex for improved drug delivery. International Journal of Pharmaceutical Sciences and Nanotechnology 2010; 3(2):940-947.
11. Ping A, Jin Y, Da-Wei C. Preparation and in-vivo behavior of didanosine pharmacosomes in rats. Chin J Pharm, 2005; 3: 227–235.
12. Vyas SP, Jaitely Vikas, Kanaujia P. Synthesis and characterisation of palymitoyl propanolol hydrochloride auto-lymphotrophs for oral administration. Int J Pharm, 1999; 186: 177-189.
13. Lawrence MJ. Surfactant Systems: Their use in drug delivery. Chem Soc Rev, 1994; 23: 417–424.
14. Muller-Goymann CC, Hamann HJ. Pharmacosomes: Multilamellar vesicles consisting of pure drug. Eur J Pharm Biopharm, 1991; 37: 113–117.
15. Singh A, Jain R. Targeted vesicular constructs for cytoprotection and treatment of H. pylori infections. US Patent 6576, 625, 2003.
16. Bombardelli E, Spelta M. Phospholipid-polyphenol complexes: A new concept in skincare ingrediants. Cosm toil, 1991; 106(3):69-76.
Published

